Aytu BioPharma, Inc (AYTU) stock
AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.84 (+46.15%)
Close on Nov 17, 2026Market cap $28.91MP/E –Yield –
Aytu BioPharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Aytu BioPharma's price to sales ratio was 0.3× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.1× to 0.5×, with a median of 0.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −0.1 |
| 2025 | Dec 31, 2025 | 0.4× | +0.2 |
| 2024 | Dec 31, 2024 | 0.2× | +0.0 |
| 2023 | Dec 29, 2023 | 0.2× | +0.0 |
| 2022 | Dec 30, 2022 | 0.1× | −0.4 |
| 2021 | Dec 31, 2021 | 0.5× | −1.4 |
| 2020 | Dec 31, 2020 | 1.9× | −0.5 |
| 2019 | Dec 31, 2019 | 2.4× | +2.0 |
| 2018 | Dec 31, 2018 | 0.4× | −2.3 |
| 2017 | Dec 29, 2017 | 2.6× | +0.2 |
| 2016 | Dec 30, 2016 | 2.4× | −203.9 |
| 2015 | Dec 31, 2015 | 206.3× | +102.0 |
| 2014 | Dec 31, 2014 | 104.2× | −87.8 |
| 2013 | Dec 31, 2013 | 192.0× | – |
See a number that looks wrong?